相关实验视频

Updated: May 3, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

DRP2促进EMT,并作为LUAD治疗的潜在治疗点

Zhimeng Chen^1,2, Hao Shi³, Wenxuan Hu^1,2

¹Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, 899 Ping Hai Road, Suzhou, 215000, Jiangsu, China.

Scientific reports

|May 13, 2025

概括

双素相关蛋白2 (DRP2) 的高表达与肺腺癌 (LUAD) 的生存率较差相关. DRP2的淘汰加速了LUAD的进展,表明其作为治疗点的潜力.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

肺腺癌 (LUAD) 是癌症死亡的主要原因.
患者的异质性需要分子向治疗.
双氨酸相关蛋白2 (DRP2) 对于膜完整性至关重要,其功能障碍与各种疾病有关.

研究的目的:

研究DRP2在LUAD进展中的作用.
为了确定DRP2在LUAD患者的预后意义.
探索DRP2作为LUAD的潜在治疗点.

主要方法:

在LUAD中对DRP2表达的生物信息分析.
使用免疫组织化学,qPCR和西式涂抹验证.
在体外和体外功能测定包括细胞增殖,迁移和转移模型.

主要成果:

在LUAD组织中DRP2的高表达与患者的生存率差有显著的相关性.
DRP2的淘汰加速了LUAD细胞的增殖,迁移和入侵.
在LUAD细胞中,DRP2敲除促进了上皮-介质细胞过渡 (EMT).

结论:

在LUAD进展中,DRP2起着至关重要的作用.
DRP2是LUAD的潜在预后生物标志物.
准DRP2可能为LUAD提供一种新的治疗策略.

关键词:

细胞循环的细胞周期在 DRP2 中使用 DRP2.在EMT中,EMT是EMT.这是入侵的入侵.肺部腺癌瘤是肺部腺癌.移民移民移民

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...